Hair Changes and Hair Care in Women Treated with Adjuvant Hormone Therapy for Breast Cancer: A Pilot Study
- Author:
Jae Kyung LEE
1
;
Chang-Hyun KIM
;
Dongkyun HONG
;
Kyung Eun JUNG
;
Young-Joon SEO
;
Chang-Deok KIM
;
Jin Sun LEE
;
In Sun KWON
;
Sanghyun PARK
;
Young LEE
Author Information
1. Departments of Dermatology, School of Medicine, Chungnam National University, Daejeon, Korea
- Publication Type:Original Article
- From:Korean Journal of Dermatology
2021;59(7):521-526
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background:Hormone therapy, which includes tamoxifen and aromatase inhibitors, is the most common adjuvant therapy used for breast cancer. However, only a few studies have reported endocrine therapy induced alopecia.
Objective:We investigated the effects of long-term adjuvant hormone therapy on hair in patients with breast cancer, in addition to patients’ concerns and current treatment for hair loss.
Methods:Patients completed a questionnaire that included information on self-perceived hair changes after each adjuvant therapy session, distress, and current treatment for hair loss. Using a folliscope, we measured hair density and thickness in each patient and in healthy controls.
Results:The study included 93 patients with breast cancer (mean age 51.9±9.8 years). The density and hair thickness were 106.36±21.85 hairs/cm2 and 0.07±0.01 mm in the patient group and 147.86±30.67 hairs/cm2 and 0.07±0.01 mm in the control group (n=98, mean age 52.10±8.40 years), respectively. The mean hair density was significantly lower in the patient group than in the control group; however, no statistically significant intergroup difference was observed in hair thickness. Among 76 patients who perceived hair changes after adjuvant therapy, 71.1% (n=54) were distressed with regard to hair changes. However, only 7.8% of the patients, including two who were treated by dermatologists, currently received treatment for hair changes.
Conclusion:Dermatologists should be familiar with hair changes in patients with breast cancer and provide appropriate education to encourage patients to consult dermatologists for hair loss and thinning after breast cancer treatment.
